Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-067039
Filing Date
2023-06-01
Accepted
2023-06-01 16:15:45
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317472-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317472-1_4seq1.xml 4 16690
  Complete submission text file 0001104659-23-067039.txt   18076
Mailing Address C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address
Gibson Neil W (Reporting) CIK: 0001555918 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38811 | Film No.: 23984840

Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Issuer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)